Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M000684200 on July 21, 2000

J. Biol. Chem., Vol. 275, Issue 41, 31908-31913, October 13, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/41/31908    most recent
M000684200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Macdonald, J. M.
Right arrow Articles by London, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Macdonald, J. M.
Right arrow Articles by London, R. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Novel Mechanism of Surface Catalysis of Protein Adduct Formation

NMR STUDIES OF THE ACETYLATION OF UBIQUITIN*

Jeffrey M. Macdonald, Arthur L. HaasDagger , and Robert E. London§

From the Laboratory of Structural Biology, NIEHS, National Institutes of Health, Research Triangle Park, North Carolina 27709 and the Dagger  Department of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin 53226

Received for publication, January 24, 2000, and in revised form, July 19, 2000


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Reactivity of surface lysyl residues of proteins with a broad range of chemical agents has been proposed to be dependent on the catalytic microenvironment of the residue. We have investigated the acetylation of wild type ubiquitin and of the UbH68N mutant to evaluate the potential contribution of His-68 to the reactivity of Lys-6, which is about 4 Å distant. These studies were performed using [1-13C]acetyl salicylate or [1,1'-13C2]acetic anhydride, and the acetylated products were detected by two-dimensional heteronuclear multiple quantum coherence spectroscopy. The results demonstrate that His-68 makes a positive contribution to the rate of acetylation of Lys-6 by labeled aspirin. Additionally, a pair of transient resonances is observed after treatment of wild type ubiquitin with the labeled acetic anhydride but not upon treatment of the H68N mutant. These resonances are assigned to the acetylated His-68 residue. The loss of intensity of the acetylhistidine resonances is accompanied by an increase in intensity of the acetyl-Lys-6 peak, supporting the existence of a transacetylation process between the acetylhistidine 68 and lysine 6 residues located on the protein surface. Hence, this may be the first direct demonstration of a catalytic intermediate forming on the protein surface.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The formation of covalent adducts by proteins and other cellular macromolecules plays an important role in the mediation of toxicity of both natural (e.g. non-enzymatic glycosylation) and synthetic (e.g. halothane trifluoroacetylation) substances. Hence, developing a mechanistic basis of such adduct formation is central to both an understanding of the structural basis for such toxicity and the development of alternate agents that may retain useful properties while exhibiting reduced tendencies to form undesirable adducts. For perhaps a majority of the examples of stable, covalent adducts that have been reported to form with proteins, linkages to lysine side chains are observed, despite the fact that at physiological pH values the lysyl epsilon -amino group is fully charged and hence a poor nucleophile. Several lines of evidence suggest that a catalytic microenvironment exists that overcomes the poor reactivity of the lysyl-NH3+ group. Thus, Nigen et al. (1) found that, whereas at neutral pH bromoacetate will modify some of the lysyl residues in myoglobin, no lysyl adducts were formed after incubation of the peptide Gly-Gly-Lys-Gly-Gly with labeled bromoacetate at pH 7.6. In this case, adducts were observed with the N-terminal glycyl amino group. Analogous observations regarding the formation of thionoacyl adducts of albumin with metabolically generated thionoacyl fluoride intermediates led to a similar conclusion and to a proposed catalytic effect of histidine or tyrosine side chains, which was studied by the addition of imidazole and phenol to the system (2).

The most extensive investigations of non-enzymatic protein modification have involved protein glycation and the formation of "advanced glycation end products" or "AGE" (3, 4), as shown in Scheme 1. It is clear from such studies that not all lysines behave equivalently, and several of these studies indicate that factors other than accessibility, in particular the existence of a catalytic microenvironment, play an important role in determining the site of glycation and the nature of the subsequent chemistry (5-11). In a number of studies involving glycation and the formation of other adducts, histidine has been proposed to play an important role in determining the reactivity of nearby lysine residues. Shilton and Walton (8) and Shilton et al. (9) have proposed that the imidazole group of His-348 facilitates the Amadori chemistry with Lys-231 in alcohol dehydrogenase via acid-base catalysis. In particular, a base supplied either by the buffer or by a nearby residue can facilitate the Amadori rearrangement by removing the proton from carbon 2 of the Schiff base-linked aldimine, and the subsequent tautomerizations are also subject to acid-base catalysis. Miyata et al. (11) similarly proposed that His-31 catalyzed Amadori rearrangement of the glycated adduct at Ile-1 in human beta 2-microglobulin. In bovine ribonuclease A, the highest degree of Amadori chemistry was reported to occur at Lys-41 (6); the Lys-41 amino group is located in close proximity to the His-12 side chain (12). The proposed catalytic role of histidine in this chemistry has led to the hypothesis that the histidine-containing dipeptide carnosine (beta -alanyl-histidine) may play a protective role in cells by rapidly forming adducts with excess sugars (13, 14).


View larger version (9K):
[in this window]
[in a new window]
 
Scheme 1.   Formation of advanced glycation end products (AGE).

As noted above, Hayden et al. (2) found that imidazole and phenol catalyzed adduct formation with metabolically generated thionoacyl fluorides. Khalifah and Sutherland (15) found that imidazole stimulated alkylation of alcohol dehydrogenase at low concentrations but was inhibitory at high concentrations. Thus, the effects of added molecules can be complex, involving both catalytic activation and competition for modification. Another complicating factor is the unique active site chemistry of each enzyme, which can trap or specifically bind particular agents. In the present study, we have used two-dimensional NMR methods to study the acetylation of a very well characterized protein, ubiquitin. Ubiquitin is a particularly attractive target for such studies because of the wealth of available structural data, the lack of an active site with its specific catalytic chemistry, and the presence of a single histidine residue located in the vicinity of Lys-6. NMR studies of the modification of ubiquitin and its H68N mutant offer a more direct approach to the analysis of the role of surface functionality in protein adduct formation.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- Ubiquitin was obtained from Sigma. Methylene chloride, pyridine, deuterium oxide, deuterium chloride, and deuterium hydroxide were purchased from Aldrich. Potassium phosphate dibasic and monobasic salts were purchased from Mallinckrodt. For dialysis, 2-kDa molecular mass cutoff slide-A-LyzerTM cassettes were purchased from Pierce. Salicylic acid was purchased from Fluka (Ronkonkoma, NY). Ethanol was purchased from Amersham Pharmacia Biotech. [1,1'-13C2]Acetic anhydride and [1-13C]acetyl chloride were purchased from Isotec, Inc. (Miamisburg, OH).

Synthesis of [1-13C]Acetyl Salicylic Acid-- [1-13C]Acetyl salicylic acid was synthesized following an approach similar to that described by Gerig et al. (16) by the reaction of [1-13C]acetyl chloride with salicylic acid. Salicylic acid (1.5 g) was dissolved in 90 ml of methylene chloride containing 1.8 ml of pyridine. A solution of 20% [1-13C]acetyl chloride (2.8 ml) in methylene chloride (11.2 ml) was added (14 ml total volume). The reaction container was capped and allowed to react for 15 h at 22 °C. The reaction container was uncapped, the methylene chloride was evaporated by heating (~45 °C), and the sample was then lyophilized. The purity of the [1-13C]acetyl salicylic acid was determined by 1H NMR to be >99%. The isotopically labeled aspirin was stored in a dessicator at 0 °C.

NMR Studies-- All NMR studies were performed on a Varian UNITY Plus 500-MHz NMR spectrometer (Palo Alto, CA). HMQC1 spectra were obtained using a 5-mm Nalorac triple resonance probe (Martinez, CA). Typical HMQC spectral parameters were as follows: spectral width of 4,504.5 Hz and 2,048 complex data points yielding an acquisition of 0.455 s with 13C WALTZ16 decoupling during acquisition, relaxation delay of 0.4 s, scalar evolution delay of 61 ms, and a 0.4-s presaturation pulse. Typically, the t1 dimension had a spectral width of 628.6 Hz and 64 increments and was collected in phase-sensitive mode. The number of increments and/or transients were varied to obtain the required resolution or signal-to-noise ratio. Two-dimensional spectra were zero-filled to 2,048 points in t1, and apodization consisted of a shifted sine-bell function. Peak volumes were calculated using the Varian VNMR software (version 5.3b) and referenced to aspirin at 174.2 ppm (13C) and 2.34 ppm (1H) when visible in the two-dimensional spectrum; all shift values are in ppm. When acetic anhydride was used as the acetylating agent, the position of the acetyl-Lys-33 resonance was set at delta 1H, delta 13C = 2.073 ppm, 174.50 ppm. Lys-33 is one of the more highly acetylated lysine residues in ubiquitin, and its chemical shift is essentially pH-independent between pH 4.95 and 9.8 (17).

The kinetics of aspirin acetylation of wt ubiquitin and H68N mutants were studied using a solution containing 8.3 mM ubiquitin or 0.4 mM H68N mutant and 40 mM [1-13C]acetyl salicylic acid in 0.2 M phosphate buffer (pH 7.4) in 100% D2O at a temperature of 37 °C. Although a high concentration of ubiquitin was used in this study to facilitate peak quantification, we found that we obtained very similar results at much lower ubiquitin concentrations; i.e. the relative reactivities of the amino groups is approximately independent of concentration (17). In addition to the HMQC parameters described above, an inverse BIRD pulse was placed in front of the HMQC sequence to suppress the increasing acetate signal that co-resonates with the signals of interest. The inverse BIRD sequence is essentially a spin echo with a scalar evolution delay of 78.1 ms, a presaturation pulse of 0.4 s, and a 1.063-s delay before the start of the HMQC sequence. Each spectrum was composed of 32 transients, resulting in a temporal resolution of 3 h. Peak volumes were calculated using the Varian VNMR software (version 5.3b). A threshold was chosen that was visually above the noise level, and the volume borders were automatically selected by the Varian software. Both peak volumes and peak heights were calculated based on the peak volume integration calculation and peak picking procedure of the software, respectively. Both measurements gave similar results, but only the peak volumes were used for graphing time courses of the reactions.

Time-dependent studies of acetic anhydride acetylation of wt ubiquitin and the H68N mutant were performed using a solution containing 4 mM ubiquitin or 0.66 mM H68N mutant and 110 mM [1,1'-13C2]acetic anhydride in 0.22 M phosphate buffer in D2O (uncorrected meter reading of pH 7.4) at a temperature of 25 °C. A preliminary kinetic study was performed to determine the optimum temporal spacing of data points. The same two-dimensional HMQC NMR parameters as described above were used. Addition of the stock acetic anhydride solutions to the protein samples resulted in initial pH values of 6.85 and 7.2 for the wt and H68N samples, respectively, which decreased to 6.50 and 6.40 after 10 h and 18 h, respectively. Additional kinetic studies were performed with 4 mM ubiquitin and 4 M or 8 M [1,1'-13C2]acetic anhydride in 0.25 M phosphate buffer (pH 5.9) in 100% D2O at a temperature of 25 °C to evaluate the effects of higher levels of acetylation. In each of these experiments, the transient resonances assigned to acetyl-His-68 were observed.

Unequivocal assignment of the acetyl-Lys-6 resonance was achieved by reacting 20 mM [1-13C]acetyl salicylate with the 0.4 mM UbK6R mutant. Acetate and unreacted aspirin were removed by dialysis, and a 1H-13C HMQC spectrum of the resulting acetylated UbK6R mutant was obtained, confirming our previous assignment (17).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

As shown previously (17), incubation of wt ubiquitin with [1-13C]acetyl salicylate results in the time-dependent formation of six adducts that give rise to resolved resonances in two-dimensional HMQC spectra. These adduct resonances have been previously assigned, and it was found that Lys-6 is the most rapidly acetylated residue, followed by Lys-48 and Lys-63. Although the order of acetylation parallels the surface availability of the residues, differences in calculated surface contact areas derived using the Connolly algorithm are in general insufficient to explain these differences. Lys-6 and Lys-48 are located near His-68 and Tyr-59, respectively. This might result in enhanced acetylation by aspirin due to pi-pi bonding or Van der Waals interactions between the aspirin and the aromatic residues. Alternatively, the proximity of Lys-6 to His-68 (the Lys-6 epsilon -amino is 4.7 Å from the imidazole C-2 carbon in the crystal (18)) introduces several alternative possible mechanisms for enhancing adduct formation. A series of HMQC spectra corresponding to 3-h accumulation periods was obtained for both the wt ubiquitin and the H68N mutant in the presence of 40 mM [1-13C]acetyl salicylate. Unexpectedly, the substitution of asparagine for histidine resulted in very little shift perturbation for the adduct acetyl resonances. We therefore confirmed our previous assignment (17) of acetyl-Lys-6 by analysis of the acetylated UbK6R mutant, as described under "Materials and Methods." This result indicates that there is no strong interaction between these side chains at the surface of the protein. The time-dependent HMQC resonance intensities for the Lys-6 and Lys-48 adducts obtained using both the wild type protein and the H68N mutant are shown in Fig. 1. From these data, it is apparent that, in contrast to the chemical shift results noted above, the nearby histidine residue does make a significant contribution to the reactivity of Lys-6. Thus, the rate of modification of Lys-6 in the H68N mutant is found to be fairly similar to the rate for Lys-48 adduct formation. These results indicate a significant promotion of the adduct formation at Lys-6 resulting from the nearby His-68 residue (Fig. 2).


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 1.   Time dependence of the peak volumes corresponding to acetyl-Lys-6 and acetyl-Lys-48 derived from two-dimensional 1H-13C HMQC spectra of ubiquitin acetylated with [1-13C]acetyl salicylic acid, obtained at the times indicated. Reactions were performed at 37 °C with 0.2 M potassium phosphate buffer in 100% D2O (pH 7.4), 40 mM [1-13C]acetyl salicylic acid, and 8.3 mM wt ubiquitin or 0.4 mM H68N mutant. Each spectrum consisted of 2,048 complex data points with a spectral width of 4,504.5 Hz in the t2 dimension, yielding an acquisition time of 0.455 s with 13C WALTZ16 decoupling during acquisition, an interpulse delay of 0.4 s, a scalar evolution delay of 61 ms, and a 0.4-s presaturation pulse. To null the acetate peak, an inverse BIRD sequence was performed before the HMQC and consisted of a scalar evolution delay of 78.1 ms, a presaturation pulse of 0.4 s, and a 1.063-s delay. The t1 dimension had a spectral width of 628.6 Hz and 64 increments and was collected in phase-sensitive mode. The two-dimensional spectra were zero-filled to 2,048 points in t1, and apodization consisted of a shifted sine-bell function. Peak volumes were calculated using the Varian VNMR software (version 5.3b). Spectra were referenced to aspirin at 174.2 ppm (13C) and 2.34 ppm (1H). In comparing the data for the wt and H68N mutant that were present at different concentrations, the peak volumes from the H68N time course were normalized by applying a weighting factor to all H68N peak volumes. The weighting factor is the ratio of the absolute peak volumes of acetyl-Lys-48 resonance obtained for wt ubiquitin relative to the H68N mutant obtained at the last data point (24 h).


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 2.   Stereo view of ubiquitin backbone showing the side chains of the lysine and His-68 residues, based on the crystallographic data of Vijay-Kumar et al. (18) and generated using the program MOLMOL (30).

The use of acetic anhydride as a protein acetylating agent is expected to result in a greater degree of acetylation of less accessible target groups, as well as more extensive acetylation of histidine residues (19, 20). In a study of the acetylation of prothrombin by acetic anhydride, acetylation of one of the histidyl residues was found to proceed so rapidly that substantial amounts of the diacetylated species were formed, with the doubly acetylated imidazole ring decomposing to yield a di-N-acetylated side chain with an opened imidazole ring and loss of the ring C-2 carbon (21). 1H-13C HMQC studies of both ubiquitin and UbH68N performed using 110 mM [1,1'-13C2]acetic anhydride confirm the greater acetylation of a residue corresponding to chemical shifts of 1H and 13C of 2.06 and 174.26 ppm, respectively, which we have previously assigned to the N-terminal methionine amino group. This result is consistent with preliminary mass spectrometry data indicating a high level of acetylation of Met-1 by acetic anhydride (22). In addition, two small resonances are observed in the upper right-hand region of the spectrum (Fig. 3A) at delta 1H, delta 13C = 1.864, 174.375 and 1.838, 174.31 ppm that are found to disappear gradually over subsequent 3-h spectral accumulation periods (Fig. 3, B and C). Such time-dependent resonance intensities presumably correspond to labile acetyl histidine or acetyl tyrosine adducts. The presence of two closely spaced resonances (Delta 13C = 0.055 ppm; Delta 1H = 0.018 ppm) would be consistent with the formation of an acetyl histidine adduct acetylated at either Nepsilon or Ntau (17). In principle, acetylation of histidine can also lead to more complex spectra because of the formation of the diacetylated species and of cis/trans isomers of each of the acetyl imidazole bonds (Delta 13C = 0.04 ppm; Delta 1H < 0.0005 ppm) (17). Hence, these spectra are most readily interpreted in terms of the formation of a labile acetyl histidine adduct. Further support for this conclusion is derived from studies of the acetylation of UbH68N by [1,1'-13C2]acetic anhydride, in which these adduct resonances are not observed (figure not shown).


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 3.   1H-13C HMQC spectra of ubiquitin subsequent to exposure to 110 mM [1,1'-13C2]acetic anhydride. Chemical shifts were referenced to acetyl-Lys-33 at delta 1H, delta 13C = 2.073, 174.50 ppm. Assignments of acetyl adducts were based on Ref. 17. NMR spectral parameters and processing were as described in Fig. 1.

Remarkably, although the acetylation of ubiquitin by acetic anhydride proceeds sufficiently rapidly so that the reaction is essentially complete by the first observation period (Fig. 4A), the time-dependent loss of intensity of the resonances assigned to acetyl-His-68 are paralleled by a time-dependent increase in the intensity of acetyl-Lys-6. In contrast, we observed no time-dependent increase in the acetyl-Lys-6 resonance of UbH68N after treatment with the same concentration of acetic anhydride (Fig. 4B). These results indicate a direct transfer of the [1-13C]acetyl moiety from acetyl-His-68 to Lys-6, as shown in Scheme 2. This behavior is consistent with the fact that acetyl imidazole is itself an acetylating agent that has been used in many studies (23-26). In addition, the apparent decrease in intensity of some of the acetyl lysine resonances in Fig. 4 probably results from minor precipitation of the acetylated ubiquitin, which is more significant for the more highly acetylated species.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 4.   Time dependence of peak volumes corresponding to the study shown in Fig. 3 (A) and to a similar study utilizing 0.66 mM H68N mutant in place of the wt ubiquitin (B). Reactions were performed at 25 °C with 0.22 M potassium phosphate buffer in 100% D2O and 110 mM [1,1'-13C2]acetic anhydride. The NMR spectral parameters and processing were the same as described in Fig. 1. In the absence of His-68, the acetylation of Lys-6 no longer exhibits the slow increase seen with the wild type enzyme.


View larger version (12K):
[in this window]
[in a new window]
 
Scheme 2.   Direct and histidine-mediated pathways for acetylation of Lys-6.

Another interesting feature of these spectra is the non-symmetric appearance of the contour corresponding to acetyl-Lys-63, which becomes particularly apparent under conditions of high levels of acetylation of the protein by acetic anhydride (Fig. 5). Fig. 5 shows a two-dimensional 1H-13C HMQC spectrum of 4.0 mM ubiquitin and 8 M acetic anhydride obtained 5.5 h into the reaction time course. In this case, the intensity of the resonance previously assigned to acetyl-Met-1 is significantly greater than in the previous study using aspirin (17). Furthermore, the acetyl-Lys-63 resonance now appears as two overlapping signals. In the crystal, the N-S distance of 3.6 Å corresponding to the Lys-63 Nalpha and the Met-1 sulfur has been suggested to correspond to a hydrogen bonding interaction (18). Hence, the data suggest that under the conditions of a high level of acetylation of the N-terminal methionine residue, there is a structural perturbation, possibly mediated by a hydrogen bonding interaction, which leads to a small shift of the resonance for acetyl-Lys-63.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 5.   1H-13C HMQC spectrum of 4 mM wt ubiquitin at 5.5 h after the addition of 8 M [1,1'-13C2]acetic anhydride at 25 °C with 0.25 M potassium phosphate buffer in 100% D2O (pH 5.9). Chemical shifts were referenced to acetyl-Lys-33 at delta 1H, delta 13C = 2.073, 174.50 ppm. Assignment of acetyl adducts was based on Ref. 17. NMR spectral parameters and processing were as described in Fig. 1.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The above results provide strong support for the conclusion that surface catalysis can contribute to the formation of adducts of proteins and, presumably, other macromolecules. In contrast to catalysis at the active site of proteins, in which very precise structural relationships are maintained, the effects observed here occur in the presence of only an average proximity of flexible side chains. Thus, for example, in the crystal structure of ubiquitin the mean ratio of the B-factors for the epsilon -amino and alpha -amino groups of Lys-6 is 3.4; the ratio of the imidazole nuclei to the alpha -amino of His-68 is 4.6 (18). The lack of a well defined interaction is also reflected in the fact that the acetyl-Lys-6 resonance shifts were nearly unaffected by the H68N residue substitution. In general, the catalytic effect observed could arise from a histidine-assisted deprotonation of the lysine side chain amino group or via the intermediacy of an acetyl histidine adduct. Support for the first alternative can be derived from the reduced pKa value observed for dimethyl-Lys-6 in reductively methylated ubiquitin (17). Alternatively, acetyl imidazole is an established acetylating agent, so the formation of a reactive acetyl imidazole side chain provides a very reasonable explanation for these results (Fig. 4).

Based on ubiquitin amine surface accessibility alone (17), one would predict that the smaller, more reactive protein-modifying agent, acetic anhydride, would have a similar residue acetylation profile to aspirin. However, Lys-6 is the third most reactive at an acetic anhydride:ubiquitin molar ratio of 13:1 (Fig. 4). The basis for this difference in reactivity is unknown at present. At very high acetic anhydride:ubiquitin ratios, the intensities for the acetyl lysine resonances of the accessible residues tend to become more similar, indicating a more complete degree of modification (e.g. Fig. 5, obtained at a ratio of 2000:1).

Transient acetyl histidine adducts have previously been reported using other methods of detection (19, 20). The factors involved in the observation of transient acetyl histidine adducts by NMR are not completely clear at present. The data obtained demonstrate that the potential significance of a catalytic microenvironment extends beyond the example of the Amadori rearrangement of Schiff's bases to other types of adducts formed with macromolecules. In fact, the most highly acetylated lysine residues by aspirin in albumin (27) and hemoglobin (28) are within several Ångstroms of a histidine residue, and transient acetyl histidine adducts may be responsible for the enhanced reactivity of certain lysine residues in these proteins as well. In addition to the role of histidine discussed above, other residues can presumably play analogous catalytic roles. Aspartyl and glutamyl carboxyl groups have also been found in the vicinity of highly glycated lysyl residues (6, 13). Similarly, tyrosyl side chains could be transiently acetylated and become involved in analogous transacetylation reactions (2). It seems likely that all of the catalytic effects observed at the active sites of enzymes may play a role in non-enzymatic protein modification, although the effects in general are expected to be considerably smaller because of the lack of defined surface residue stereochemical constraints (29).

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Laboratory of Structural Biology, MR-01, National Institute of Environmental Health Sciences, Box 12233, Research Triangle Park, NC 27709. Tel.: 919-541-4879; Fax: 919-541-5707; E-mail: london@niehs.nih.gov.

Published, JBC Papers in Press, July 21, 2000, DOI 10.1074/jbc.M000684200

    ABBREVIATIONS

The abbreviations used are: HMQC, heteronuclear multiple quantum coherence; BIRD, bilinear rotation decoupling; wt, wild type; UbH68N, ubiquitin with the histidine at position 68 replaced by asparagine.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Nigen, A. M., Keim, P., Marshall, R. C., Morrow, J. S., Vigna, R. A., and Gurd, F. R. N. (1973) J. Biol. Chem. 248, 3724-3732
2. Hayden, P. J., Yang, Y., Ward, A. J. I., Dulik, D. M., McCann, D. J., and Stevens, J. L. (1991) Biochemistry 30, 5935-5943
3. Bailey, A. J., Paul, R. G., and Knott, L. (1998) Mech. Ageing Dev. 106, 1-56
4. Brownlee, M. (1995) Annu. Rev. Med. 46, 223-234
5. Acharya, A. S., Sussman, L. G., and Manning, J. M. (1983) J. Biol. Chem. 258, 2296-2302
6. Watkins, N. G., Thorpe, S. R., and Baynes, J. W. (1985) J. Biol. Chem. 260, 10629-10639
7. Iberg, N., and Fluckiger, R. (1986) J. Biol. Chem. 261, 13542-13545
8. Shilton, B. H., and Walton, D. J. (1991) J. Biol. Chem. 266, 5587-5592
9. Shilton, B. H., Campbell, R. L., and Walton, D. J. (1993) Eur. J. Biochem. 215, 567-572
10. Nacharaju, P., and Acharya, A. S. (1992) Biochemistry 31, 12673-12679
11. Miyata, T., Inagi, R., Wada, Y., Ueda, Y., Ilda, Y., Takahashi, M., Taniguchi, N., and Maeda, K. (1994) Biochemistry 33, 12215-12221
12. Wlodawer, A., and Sjolin, L. (1983) Biochemistry 22, 2720-2728
13. Baldwin, J. S., Lee, L., Leung, T. K., Muruganandam, A., and Mutus, B. (1995) Biochim. Biophys. Acta 1247, 60-64
14. Hipkiss, A. R., Michaelis, J., and Syrris, P. (1995) FEBS Lett. 371, 81-85
15. Khalifah, R. G., and Sutherland, W. M. (1979) Biochemistry 18, 391-398
16. Gerig, J. T., Katz, K. E., Reinheimer, J. D., Sullivan, G. R., and Roberts, J. D. (1981) Org. Magn. Reson. 15, 158-161
17. Macdonald, J. M., LeBlanc, D. A., Haas, A. L., and London, R. E. (1999) Biochem. Pharmacol. 57, 1233-1244
18. Vijay-Kumar, S., Bugg, C. E., and Cook, W. J. (1987) J. Mol. Biol. 194, 531-544
19. Moore, G. J. (1985) Int. J. Pept. Protein Res. 26, 469-481
20. Kinnunen, P. M., DeMichele, A., and Lange, L. G. (1988) Biochemistry 27, 7344-7350
21. Welsch, D. J., and Nelsestuen, G. L. (1988) Biochemistry 27, 7513-7519
22. Wunderlin, M. (1994) Diplom. thesis, University of Konstanz, Germany
23. Riordan, J. F., Wacker, W. E. C, and Vallee, B. L. (1965) Biochemistry 4, 1758-1765
24. de Satz, V. B., and Santome, J. A. (1981) Int. J. Pept. Protein Res. 18, 492-499
25. Kaliman, P., Ermacora, M. R., Nowicki, C., Wolfenstein-Todel, C., and Santome, J. A. (1991) Int. J. Pept. Protein Res. 38, 38-46
26. Arguello, J. M., and Kaplan, J. H. (1990) Biochemistry 29, 5775-5782
27. Walker, J. E. (1975) FEBS Lett. 66, 173-175
28. Xu, A. S. L., Macdonald, J. M., Labotka, R. J., and London, R. E. (1999) Biochim. Biophys. Acta 1432, 333-349
29. Svensson, L. A., Sjolin, L., Gilliland, G. L., Finzel, B. C., and Wlodawer, A. (1986) Proteins 1, 370-375
30. Koradi, R., Billeter, M., and Wuthrich, K. (1996) J. Mol. Graphics 14, 29-32, 51-55


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
F. Shang, G. Deng, Q. Liu, W. Guo, A. L. Haas, B. Crosas, D. Finley, and A. Taylor
Lys6-modified Ubiquitin Inhibits Ubiquitin-dependent Protein Degradation
J. Biol. Chem., May 27, 2005; 280(21): 20365 - 20374.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/41/31908    most recent
M000684200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Macdonald, J. M.
Right arrow Articles by London, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Macdonald, J. M.
Right arrow Articles by London, R. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement